For semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), the Summaries of Product Characteristics confirm that the injection site does not significantly affect the pharmacokinetics of these medications
Individual results vary based on starting weight, diet quality, exercise habits, and dose achieved
The blend is disclosed by weight, at 36 mg total, with no CFU (colony-forming unit) count and no live-versus-pasteurized status stated for Akkermansia muciniphila specifically - a detail that matters, since the human research on this strain (a randomized trial in Nature Medicine ) used a pasteurized form dosed by cell count, not by weight
NICE would conduct a technology appraisal before any NHS commissioning could occur following potential approval
What Else is New with GLP-1s While much of the news about health insurance coverage for GLP-1s is bad, there's good news too